News

Articles

World Atopic Eczema Day Marked with ISPD x ISAD Event on September 14
26 Aug 2026

World Atopic Eczema Day Marked with ISPD x ISAD Event on September 14

ISAD and ISPD marked World Atopic Eczema Day on September 14 by urging equitable, affordable access to the …

6f70197dd14b6dae738781b15618730bd5dbe949f73b72e33121abaecad3b359
25 Aug 2026 Clinical Trials

Rezpegaldesleukin Opens a Different Route in Atopic Dermatitis: Restoring Immune Regulation

Phase 2b results show rezpegaldesleukin significantly improved eczema severity, itch and quality of life in adults with moderate-to-severe …

ljag343_ga
20 Aug 2026 Research

Non-Invasive Technology May Detect Atopic Dermatitis Inflammation Before We Can See It

New noninvasive biomarker models can objectively assess atopic dermatitis severity and detect hidden inflammation even in skin that …

ISAD Awards MEDIATE Initiative for Topical Steroid Withdrawal Project
31 Jul 2026

ISAD Awards MEDIATE Initiative for Topical Steroid Withdrawal Project

The International Society of Atopic Dermatitis has funded the MEDIATE Initiative, a project developing an AI-powered digital agent …

455f9711634f285a0989953a746a1872f931794149d590d6c8095d9455a0d711
30 Jul 2026 HTA

NICE Moves Forward With Evaluation of Topical Tapinarof for Atopic Dermatitis

NICE is evaluating lebrikizumab for treating moderate-to-severe atopic dermatitis in children and young people, assessing its clinical and …

031bf92e99040720cb8b6e1cdfe3276ffa0f6a2b5623dcd9b76a9818a10eb280
24 Jul 2026 Industry

Sanofi Stops Amlitelimab Development in Atopic Dermatitis After Reviewing Phase 3 Evidence

Sanofi ends development of amlitelimab for atopic dermatitis after concluding that available efficacy and safety data do not …

Bridging Care and Science in the Heart of the Amazon
12 Jun 2026

Bridging Care and Science in the Heart of the Amazon

ISAD Vice-President Dr Roberto Takaoka visited Manaus to help launch a new patient support group and highlight the …